Author

Liping Li

The University of Texas Southwestern Medical CenterORCID 0000-0001-7396-1310Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Liping LI3 papers · Chinese University of Hong Kong

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andrew S. LemoffiD· 1 shared Ann Marie FluschéiD· 1 shared Bingnan Wang· 1 shared Chiho KimiD· 1 shared Chuo CheniD· 1 shared Ilgen MenderiD· 1 shared Jerry W. ShayiD· 1 shared Lawrence LumiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew S. LemoffORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 22, 2025

Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in cancer

Qian Wang, Liping Li, Lin You…·Chuo Chen

This study shows that degrading tankyrase (TNKS) with PROTACs overcomes the limitations of catalytic inhibitors by preventing AXIN puncta formation and enhancing WNT/β-catenin pathway suppression in colorectal cancer.

1 citation

humanexperimental assay

𝕏 PostBluesky